Insider Transactions in Q3 2022 at Sierra Oncology, Inc. (SRRA)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 01
2022
|
Stephen George Dilly CEO and President |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,000
-100.0%
|
$275,000
$55.0 P/Share
|
|
Jul 01
2022
|
Craig A Collard Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,500
-100.0%
|
$742,500
$55.0 P/Share
|
|
Jul 01
2022
|
Andrew R Allen Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,650
-100.0%
|
$90,750
$55.0 P/Share
|
|
Jul 01
2022
|
Barbara Klencke Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
5,000
-100.0%
|
$275,000
$55.0 P/Share
|
|
Jul 01
2022
|
Barbara Klencke Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,000
-100.0%
|
$550,000
$55.0 P/Share
|
|
Jul 01
2022
|
Andrew Sinclair Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1,314,127
-100.0%
|
$72,276,985
$55.0 P/Share
|
|
Jul 01
2022
|
Gaurav Aggarwal Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
2,735,853
-100.0%
|
$150,471,915
$55.0 P/Share
|
|
Jul 01
2022
|
Mona Ashiya Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1,964,770
-100.0%
|
$108,062,350
$55.0 P/Share
|
|
Jul 01
2022
|
Vivo Opportunity, LLC Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
3,329,512
-100.0%
|
$183,123,160
$55.0 P/Share
|
|
Jul 01
2022
|
Orbimed Advisors LLC Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1,964,770
-100.0%
|
$108,062,350
$55.0 P/Share
|